Xencor, Inc Accounts Payable
Xencor, Inc (XNCR) had Accounts Payable of $12.65 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-08-05
- 2026-06-30: Accounts Payable, Current $12.65M.
- 2026-03-31: Accounts Payable, Current $7.92M.
- 2025-12-31: Accounts Payable, Current $10.83M.
- 2025-09-30: Accounts Payable, Current $9.08M.
| Period end | Accounts Payable, Current |
|---|---|
| 2026-06-30 | $12.65M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $7.92M 10-Q · filed 2026-05-06 |
| 2025-12-31 | $10.83M 10-Q · filed 2026-08-05 |
| 2025-09-30 | $9.08M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $18.53M 10-Q · filed 2025-08-06 |
| 2025-03-31 | $16.19M 10-Q · filed 2025-05-07 |
| 2024-12-31 | $16.76M 10-K · filed 2026-02-25 |
| 2024-09-30 | $18.77M 10-Q/A · filed 2025-02-24 |
| 2024-06-30 | $15.84M 10-Q/A · filed 2025-02-24 |
| 2024-03-31 | $16.01M 10-Q/A · filed 2025-02-24 |
| 2023-12-31 | $13.91M 10-K · filed 2025-02-27 |
| 2023-09-30 | $14.97M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $14.10M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $15.34M 10-Q · filed 2023-05-08 |
| 2022-12-31 | $10.09M 10-K/A · filed 2025-02-24 |
| 2022-09-30 | $14.62M 10-Q · filed 2022-11-07 |
| 2022-06-30 | $15.75M 10-Q · filed 2022-08-03 |
| 2022-03-31 | $11.90M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $14.00M 10-K · filed 2023-02-27 |
| 2021-09-30 | $9.13M 10-Q · filed 2021-11-08 |
| 2021-06-30 | $7.11M 10-Q · filed 2021-08-04 |
| 2021-03-31 | $7.66M 10-Q · filed 2021-05-05 |
| 2020-12-31 | $8.95M 10-K · filed 2022-02-24 |
| 2020-09-30 | $13.11M 10-Q · filed 2020-11-06 |
| 2020-06-30 | $10.51M 10-Q · filed 2020-08-05 |
| 2020-03-31 | $10.31M 10-Q · filed 2020-05-08 |
| 2019-12-31 | $10.19M 10-K · filed 2021-02-24 |
| 2019-09-30 | $8.30M 10-Q · filed 2019-11-05 |
| 2019-06-30 | $8.99M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $5.49M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $3.80M 10-K · filed 2020-02-25 |
| 2018-09-30 | $5.98M 10-Q · filed 2018-11-05 |
| 2018-06-30 | $4.92M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $8.52M 10-Q · filed 2018-05-07 |
| 2017-12-31 | $6.87M 10-K · filed 2019-02-26 |
| 2017-09-30 | $6.60M 10-Q · filed 2017-11-08 |
| 2017-06-30 | $7.38M 10-Q · filed 2017-08-07 |
| 2017-03-31 | $4.28M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $3.88M 10-K · filed 2018-02-28 |
| 2016-09-30 | $7.33M 10-Q · filed 2016-11-02 |
| 2016-06-30 | $7.69M 10-Q · filed 2016-08-03 |
| 2016-03-31 | $4.29M 10-Q · filed 2016-05-02 |
| 2015-12-31 | $6.40M 10-K · filed 2017-03-01 |
| 2015-09-30 | $5.11M 10-Q · filed 2015-11-04 |
| 2015-06-30 | $3.08M 10-Q · filed 2015-08-05 |
| 2015-03-31 | $2.56M 10-Q · filed 2015-05-05 |
| 2014-12-31 | $1.69M 10-K · filed 2016-03-08 |
| 2014-09-30 | $2.10M 10-Q · filed 2014-11-10 |
| 2014-06-30 | $1.37M 10-Q · filed 2014-08-01 |
| 2014-03-31 | $2.10M 10-Q · filed 2014-05-15 |
| 2013-12-31 | $2.63M 10-K · filed 2015-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |